Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Accounts Payable & Accrued Expense : ¥373 Mil (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co Accounts Payable & Accrued Expense?

Wanbangde Pharmaceutical Holding Group Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥326 Mil) to Dec. 2023 (¥415 Mil) but then declined from Dec. 2023 (¥415 Mil) to Mar. 2024 (¥373 Mil).

Wanbangde Pharmaceutical Holding Group Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥571 Mil) to Dec. 2022 (¥352 Mil) but then increased from Dec. 2022 (¥352 Mil) to Dec. 2023 (¥415 Mil).

Wanbangde Pharmaceutical Holding Group Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co Accounts Payable & Accrued Expense Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

559.00

676.93

570.88

352.47

415.03

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															373.00	364.90	326.01	415.03	373.26

Wanbangde Pharmaceutical Holding Group Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008

Website

http://www.wepon.com.cn

Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.

Executives

Zhao Shou Ming	Directors, executives
Wang Tian Fang	Director
Li Rong Fang	Supervisors
Zhu Jian Xin	Directors, executives
Yang Jin Rong	Executives
Song Tie He	Directors, executives
Song Jian Hua	Executives
Pan Yun Chu	Director
Yu Ju Ming	Executives
Yang Mei Gen	Executives
Tao Jian Feng	Supervisors
Qian Shu Sheng	Executives
Shen Bai Ming	Director
Xu Yin Sheng	Director
Shuang Zhi Wei	Executives

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Headlines

No Headlines